Novotech recently attended the NECTA Drug Development Meeting 2025 in Sydney, where industry leaders gathered to discuss the future of drug development across the Asia-Pacific region. Our team had the opportunity to connect with biotech innovators, engage in productive discussions, and share expert insights on: • Global Phase I strategies • Theranostics in clinical trials • Advancing early-phase clinical trials in Australia Thank you to everyone who took the time to meet with us. If we missed you, we’d welcome the opportunity to connect. Contact us to learn how Novotech’s early-phase expertise can support your clinical development strategy: https://lnkd.in/dKXKvtNh Julie Gargano, Joanne Hawking, Malia Rogers, Passant Zaki, Dr. Yifan Chen, MD/ PhD, Javiera Kaiser, Dhanya Nair #Novotech #DrugDevelopment #EarlyPhase
